Status:

RECRUITING

Dextromethorphan for Treatment of Postoperative Pain

Lead Sponsor:

Nathanael Heckmann

Conditions:

Post-operative Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Perioperative Dextromethorphan compared to Placebo for the Treatment of Postoperative Pain

Detailed Description

There is extensive preclinical evidence that dextromethorphan has an analgesic effect in patients with pain of traumatic origin. The primary objective is to of this study is to evaluate the efficacy o...

Eligibility Criteria

Inclusion

  • Main
  • Patients Age ≥18 planning to undergo total knee arthroplasty
  • ASA classes I - III
  • Main

Exclusion

  • BMI ≥ 35
  • History opioid abuse
  • History of intractable vomiting after previous surgery

Key Trial Info

Start Date :

September 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT05278494

Start Date

September 15 2022

End Date

December 31 2026

Last Update

December 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Keck School of Medicine of USC

Los Angeles, California, United States, 90033

Dextromethorphan for Treatment of Postoperative Pain | DecenTrialz